Why Are These Four Stocks Gaining Ground on Monday?

Relypsa Inc (NASDAQ:RLYP)‘s stock has gained around 9% in the Monday intraday trading, extending the gains of the last couple of days that came on the back of the third-quarter results. The company posted a net loss of $1.24, missing the estimates of $0.89, on revenue of $6.6 million, compared to flat revenue a year earlier. Several analysts raised their estimates on the company’s future earnings on the back of the results last week. Moreover, other analysts reiterated their bullish outlooks on the stock, which currently sports a consensus ‘Buy’ rating and a $50.70 price target. In a recent 13D filing, Samuel Isaly’s Orbimed Advisors reported an increased stake in Relypsa Inc (NASDAQ:RLYP), which contained 7.9 million shares, compared to 7.4 million shares held earlier. Overall, the sentiment among the investors we follow is positive with 28 funds holding nearly 30% of Relypsa Inc (NASDAQ:RLYP)’s stock as of the end of June.

Last but not least, Impax Laboratories Inc (NASDAQ:IPXL)‘s stock has grown by almost 8% after the company reported its financial results for the third quarter, posting EPS of $0.40, above the consensus estimate of $0.39, while the revenue of $221.10 million, was better than $214.10 million estimated by the Street. During the second quarter, the number of investors bullish on Impax Laboratories Inc (NASDAQ:IPXL) went up to 31 from 21, while the aggregate value of their holdings was equal to more than 31% of the company at the end of June.

Disclosure: none